Navigation Links
/C O R R E C T I O N - Mindray Medical International Limited /
Date:9/3/2010

/C O R R E C T I O N - Mindray Medical... -- SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

/C O R R E C T I O N - Mindray Medical International Limited /

   

In the news release, "Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference," issued Wednesday, August 25, by Mindray Medical International Limited (NYSE: MR) over PR Newswire Asia, we are advised by the company that Mr. Ronald Ede, instead of both Mr. Ronald Ede and Mr. Minghe Cheng, will attend the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference, as originally issued inadvertently. The complete, corrected release follows.Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference

SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference in London on September 8th, 2010. Mr. Ronald Ede will present on behalf of Mindray.

The Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference will be attended by Mr. Ronald Ede, Mindray's chief financial officer. The conference will take place at Goldman Sachs' offices, located at 120 Fleet Street in London, UK, from Wednesday, September 8th to Thursday, September 9th, 2010. Mr. Ronald Ede will present on Wednesday, September 8th at 01:45 pm GMT.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com.

For investor and media inquiries please contact: In the US: John Capodanno FD Tel: +1-212-850-5705 Email: john.capodanno@fd.com Bryan Armstrong FD Tel: +1-312-553-6707 Email: bryan.armstrong@fd.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: ir@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... Hamlin Dental Group, multi-location dental office in North Hollywood , Van ... safe and effective options, and can be used alone or in conjunction with other ... care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as well, ...
(Date:3/29/2017)... ... , ... VisualSP has helped over 1.5 million SharePoint users learn the content ... of its Help System for SharePoint was at the farm level. Enterprises using SharePoint ... , The company recently released a modified version of the Help System, VisualSP ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... team. Ruel Williamson brings his extensive knowledge of appraisals, property values, ad valorem ... the real estate valuation industry for more than 40 years. , “Ruel is ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
Breaking Medicine News(10 mins):